Lansoprazole Tablet, Orally Disintegrating, Delayed Release
NDC Package 72288-672-55
Package Information
Lansoprazole tablets is •adults 18 years of age and older•this product is to be used once a day (every 24 hours), every day for 14 days•it may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours14-Day Course of Treatment•take 1 tablet before eating in the morning•do not crush or chew tablets•place the tablet on tongue; tablet disintegrates, with or without water. This formulation utilizes a tablet, orally disintegrating, delayed release delivery system. Marketed by Amazon.com Services Llc, this product is identified by NDC 72288-672 and is authorized under FDA application NDA208025.
Identification & Billing
- RxCUI: 351261 - lansoprazole 15 MG Delayed Release Disintegrating Oral Tablet
- RxCUI: 351261 - lansoprazole 15 MG Disintegrating Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72288 - Amazon.com Services Llc
- 72288-672 - Lansoprazole
- 72288-672-55 - 3 CARTON in 1 CARTON / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
- 72288-672 - Lansoprazole
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72288-672-55 identifies a specific commercial package of 3 carton in 1 carton / 14 blister pack in 1 carton / 1 tablet, orally disintegrating, delayed release in 1 blister pack of Lansoprazole, a human over the counter drug labeled by Amazon.com Services Llc. This tablet, orally disintegrating, delayed release is formulated for oral use and contains lansoprazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amazon.com Services Llc on August 12, 2026. The current certification is valid through December 31, 2027.
How is this Amazon.com Services Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72288067255. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.